Precipio to report $15.2m for fy-2023 (unaudited) revenues, an increase of 60% yoy

New haven, conn., feb. 13, 2024 (globe newswire) -- specialty cancer diagnostics company precipio, inc. (nasdaq: prpo) , announces that for the full year of 2023, its unaudited revenues have grown from $9.4m in 2022 to $15.2m in 2023, an increase of 60% year over year.

PRPO Ratings Summary

PRPO Quant Ranking